TP53 and central nervous system cancer: Zixi Yang et al. showed that IDH-mu only and the combination of IDH-mu and MGMTp-M with or without 1p/19q-codel carry a favorable prognosis in high-grade gliomas, wihle p53+/Ki-67 + predicts adverse outcomes in these patients.